CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Indofarma Tbk PT is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Indofarma Tbk PT
Jl. Indofarma No. 1, Cikarang Barat
Phone: +62 2188323971p:+62 2188323971 BEKASI, 17530  Indonesia Ticker: INAFINAF
Business Summary
PT Indofarma Tbk is an Indonesia-based company, which is engaged in the healthcare industry. Its business segment based on the products consists of pharmaceutical business segment and the other medical equipment business segment. The medical equipment segment consists of diagnostic and medical equipment. Its business segment based on geographical distribution area covers five regions consisting of Sumatra, Java, Kalimantan, Sulawesi and Bali, West Nusa Tenggara, and East Indonesia. Its products and services include generic drugs, over the counter and food, medical devices, non-medical devices, and household health products. Its carries out business activities to produce either alone or under cooperation for finished drug products, such as essential medicines, generic medicines with logos, generic medicines with trade names, traditional medicines, medical equipment, diagnostics, as well as food products, both related to health maintenance and improvement as well as health restoration.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
5047 Medical, dental, and hospital equipment and supplies
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President Commissioner LaksonoTrisnantoro 60 5/20/2021 5/20/2021
President Director AriefPramuhanto 60 5/7/2019 5/7/2019
Finance, Risk Management and Human Resources Director SahatSihombing 55 5/20/2021 5/20/2021
3 additional Officers and Directors records available in full report.

Business Names
Business Name
INAF
P.T. Indofarma (Persero) Tbk
PT Indofarma (Persero) Tbk

General Information
Number of Employees: 833 (As of 9/30/2024)
Outstanding Shares: 3,099,267,500 (As of 9/30/2024)
Stock Exchange: JAK
Fax Number: +62 2188323972


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024